Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Molecular Therapy. Methods & Clinical Development
|
November 14, 2019
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform
Shabnum Patel, Ryo Hanajiri, Melanie Grant, et al.
Blood Advances
|
July 23, 2020
Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy
Jeremy D Rubinstein, Xiang Zhu, Carolyn Lutzko, et al.
Cytotherapy
|
March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trials
Patrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Molecular Therapy. Methods & Clinical Development
|
October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
Allison B Powell, Yanqin Ren, Maria Korom, et al.
The Annals of Thoracic Surgery
|
August 11, 2022
Dose Effect of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass
Kei Kobayashi, Takuya Maeda, Mobolanle Ayodeji, et al.
Cytotherapy
|
May 5, 2011
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
Patrick J Hanley, Donald R Shaffer, Conrad R Y Cruz, et al.
The Journal of Infectious Diseases
|
September 29, 2019
Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy
Ryo Hanajiri, Gelina M Sani, Devin Saunders, et al.
Cytotherapy
|
October 4, 2016
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes
Lauren P McLaughlin, Haili Lang, Elizabeth Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 1, 2014
Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells
Jan J Melenhorst, Paul Castillo, Patrick J Hanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency
Holly K Miller, Patrick J Hanley, Haili Lang, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Molecular Therapy. Methods & Clinical Development
|
November 14, 2019
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform
Shabnum Patel, Ryo Hanajiri, Melanie Grant, et al.
Blood Advances
|
July 23, 2020
Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy
Jeremy D Rubinstein, Xiang Zhu, Carolyn Lutzko, et al.
Cytotherapy
|
March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trials
Patrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Molecular Therapy. Methods & Clinical Development
|
October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
Allison B Powell, Yanqin Ren, Maria Korom, et al.
The Annals of Thoracic Surgery
|
August 11, 2022
Dose Effect of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass
Kei Kobayashi, Takuya Maeda, Mobolanle Ayodeji, et al.
Cytotherapy
|
May 5, 2011
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
Patrick J Hanley, Donald R Shaffer, Conrad R Y Cruz, et al.
The Journal of Infectious Diseases
|
September 29, 2019
Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy
Ryo Hanajiri, Gelina M Sani, Devin Saunders, et al.
Cytotherapy
|
October 4, 2016
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes
Lauren P McLaughlin, Haili Lang, Elizabeth Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 1, 2014
Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells
Jan J Melenhorst, Paul Castillo, Patrick J Hanley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency
Holly K Miller, Patrick J Hanley, Haili Lang, et al.
Page
of 10